Molecular signatures of inherited and acquired sporadic late onset

Por um escritor misterioso
Last updated 18 novembro 2024
Molecular signatures of inherited and acquired sporadic late onset
Acquired sporadic late onset nemaline myopathy (SLONM) and inherited nemaline myopathy (iNM) both feature accumulation of nemaline rods in muscle fibers. Unlike iNM, SLONM is amenable to therapy. The distinction between these disorders is therefore crucial when the diagnosis remains ambiguous after initial investigations. We sought to identify biomarkers facilitating this distinction and to investigate the pathophysiology of nemaline rod formation in these different disorders. Twenty-two muscle samples from patients affected by SLONM or iNM underwent quantitative histological analysis, laser capture microdissection for proteomic analysis of nemaline rod areas and rod-free areas, and transcriptomic analysis. In all iNM samples, nemaline rods were found in subsarcolemmal or central aggregates, whereas they were diffusely distributed within muscle fibers in most SLONM samples. In SLONM, muscle fibers harboring nemaline rods were smaller than those without rods. Necrotic fibers, increased endomysial connective tissue, and atrophic fibers filled with nemaline rods were more common in SLONM. Proteomic analysis detected differentially expressed proteins between nemaline rod areas and rod-free areas, as well as between SLONM and iNM. These differentially expressed proteins implicated immune, structural, metabolic, and cellular processes in disease pathophysiology. Notably, immunoglobulin overexpression with accumulation in nemaline rod areas was detected in SLONM. Transcriptomic analysis corroborated proteomic findings and further revealed substantial gene expression differences between SLONM and iNM. Overall, we identified unique pathological and molecular signatures associated with SLONM and iNM, suggesting distinct underlying pathophysiological mechanisms. These findings represent a step towards enhanced diagnostic tools and towards development of treatments for SLONM.
Molecular signatures of inherited and acquired sporadic late onset
Molecular signatures of inherited and acquired sporadic late onset
Molecular signatures of inherited and acquired sporadic late onset
Ferroptosis, Pyroptosis, and Cuproptosis in Alzheimer's Disease
Molecular signatures of inherited and acquired sporadic late onset
The cytoskeleton in neurodegenerative diseases - Cairns - 2004
Molecular signatures of inherited and acquired sporadic late onset
The Coming Alzheimer's Epidemic, the Cholinergic Hypothesis, and
Molecular signatures of inherited and acquired sporadic late onset
Development and physiological functions of the lymphatic system
Molecular signatures of inherited and acquired sporadic late onset
Comparative analysis of protein changes. A Venn diagram depicting
Molecular signatures of inherited and acquired sporadic late onset
A microRNA signature that correlates with cognition and is a
Molecular signatures of inherited and acquired sporadic late onset
Clonal hematopoiesis of indeterminate potential (CHIP): Linking
Molecular signatures of inherited and acquired sporadic late onset
Alzheimer's disease associated with Down syndrome: a genetic form
Molecular signatures of inherited and acquired sporadic late onset
Genetic predisposition to gastrointestinal polyposis: syndromes
Molecular signatures of inherited and acquired sporadic late onset
Epigenomes, Free Full-Text
Molecular signatures of inherited and acquired sporadic late onset
miRNA biogenesis and inherited disorders: clinico-molecular
Molecular signatures of inherited and acquired sporadic late onset
Single-cell genomics in acquired bone marrow failure syndromes

© 2014-2024 tokoonline2.msd.biz.id. All rights reserved.